Answers are grounded in this paper and cite their sources.
@SP-PLGA lipo-polymersome with enhanced ROS-generation characteristics provides a general approach to afford potent ROS-mediated cancer therapy.
No takes yet. Share an insight, caveat, or question.
You et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: